| Journal | Harm reduction journal |
| Study Type | Clinical Study |
| Population | Human participants |
This study addresses a critical gap in understanding how veterans with substance use disorders view cannabis as both pain management and harm reduction within treatment programs. The findings could inform more nuanced, patient-centered approaches to SUD treatment that acknowledge the complex relationship between pain, addiction, and cannabis use in veteran populations.
This qualitative study interviewed 33 U.S. military veterans with chronic pain enrolled in a VA substance use disorder treatment program that permits continued cannabis use as harm reduction. The research explored veteran perspectives on using cannabis to manage chronic pain, pain-related anxiety, and sleep disturbances while receiving treatment for non-cannabis substance use disorders. The study design allows for polysubstance use as long as patients commit to abstaining from their primary problematic substance. Key findings characterize how veterans conceptualize cannabis use within their broader recovery and pain management strategies.
“This study illuminates an important clinical reality many providers face but rarely discuss openly—patients using cannabis as substitution therapy within traditional SUD treatment frameworks. The veteran population’s unique pain burden and substance use patterns make this particularly relevant for understanding real-world treatment approaches.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- Can cannabis be safely used during substance use disorder treatment?
- Is cannabis effective for chronic pain management in veterans?
- How does harm reduction differ from traditional abstinence-based SUD treatment?
- What are the clinical considerations for cannabis use in veterans with SUD?
- Should clinicians consider cannabis as part of comprehensive pain management in SUD treatment?
FAQ
Can cannabis be safely used during substance use disorder treatment?
This study examined a harm reduction SUD treatment model that allows continued cannabis use while patients work toward abstaining from their primary substance of abuse. The approach recognizes that cannabis may serve as a less harmful substitute and therapeutic tool for managing chronic pain and related symptoms in veterans with polysubstance use disorders.
Is cannabis effective for chronic pain management in veterans?
Evidence supports cannabis as an effective treatment for pain, and this study specifically explored veteran perspectives on using cannabis to manage chronic pain during SUD treatment. Veterans reported using cannabis not only for pain relief but also for associated symptoms like pain-related anxiety and poor sleep quality.
How does harm reduction differ from traditional abstinence-based SUD treatment?
Unlike traditional SUD treatment models that require complete abstinence from all substances, harm reduction approaches allow continued use of less harmful substances as a therapeutic strategy. This study examined a program where veterans could continue cannabis use while committing to abstain from their primary substance of abuse.
What are the clinical considerations for cannabis use in veterans with SUD?
Veterans with SUD represent a unique population with high rates of chronic pain and complex trauma histories. This study suggests that cannabis may serve multiple therapeutic functions in this population, addressing pain, anxiety, and sleep disturbances while potentially reducing reliance on more harmful substances.
Should clinicians consider cannabis as part of comprehensive pain management in SUD treatment?
With two-thirds of U.S. adults finding cannabis use acceptable and growing evidence of its therapeutic benefits, clinicians should consider individualized approaches that may include cannabis for pain management. This study provides insight into patient perspectives that can inform more personalized, harm reduction-oriented treatment strategies for veterans with co-occurring chronic pain and SUD.